Skip to content

YnoraMed

Active
Private limited companyfounded 20241 yr activePijpenhof 29A, 3740 Bilzen-Hoeselt, BelgiumKBO/BCE: BE 1017.416.073
Summary

YnoraMed has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €148,340 and a net result of €145,840. The computed 12-month bankruptcy probability is 1.5% (low).

Checked score

Score 2025
Axes
Profitability100
Solvency100
Growth-
Track record67
Bankruptcy probability, 12 months
1.5% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €12,000 at 30 days only on tighter terms
Liquidity ample (current ratio 4.27; short-term debt: 23.4% and cash: 83.9% of total assets), and 23.4% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
76.6%
Return on assets
75.3%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-09-2026, 42 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
42 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 16 December 2024, YnoraMed was incorporated as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€148,340
Total assets
€193,723
Net result
€145,840
Working capital
€148,340

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Equity and liabilities €193,723
Equity €148,340
Debt €45,384
Debt finances 23.4% of the balance-sheet total.
Key figures and ratios
2025 value
Current ratio
4.27
Debt to equity
0.31
ROE
98.3%
ROA
75.3%
Debt ≤ 1 year
€45,384
Income taxes
€41,960

Peer companies

Historical observation

Of the 11,279 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 97% are still going.

  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
2.6% stopped otherwise
97% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a higher bankruptcy probability: 1.5% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 11,279 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 24 lines
Balance sheet Code2025
Assets
Total assets20/58€193,723
Current assets29/58€193,723
Cash at bank and in hand54/58€162,600
Deferred charges and accrued income490/1€31,123
Equity and liabilities
Total equity and liabilities10/49€193,723
Equity10/15€148,340
Contributions10/11€2,500
Profit (loss) carried forward14€145,840
Amounts payable17/49€45,384
Amounts payable within one year42/48€45,384
Trade debts44€434
Suppliers440/4€434
Taxes, remuneration and social security45€41,960
Taxes450/3€41,960
Other amounts payable47/48€2,990
Income statement Code2025
Gross operating margin9900€187,875
Operating profit (loss)9901€187,875
Financial charges65/66B€76
Recurring financial charges65€76
Profit (loss) for the period before taxes9903€187,800
Income taxes67/77€41,960
Profit (loss) for the period9904€145,840
Profit (loss) for the period to be appropriated9905€145,840
Appropriation of the result
Profit (loss) to be appropriated9906€145,840

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Gross operating margin9900€187,875
Operating profit (loss)9901€187,875
Financial charges65/66B€76
Recurring financial charges65€76
Profit (loss) for the period before taxes9903€187,800
Income taxes67/77€41,960
Profit (loss) for the period9904€145,840
Profit (loss) for the period to be appropriated9905€145,840
Line2025
Assets
Total assets20/58€193,723
Current assets29/58€193,723
Cash at bank and in hand54/58€162,600
Deferred charges and accrued income490/1€31,123
Equity and liabilities
Total equity and liabilities10/49€193,723
Equity10/15€148,340
Contributions10/11€2,500
Profit (loss) carried forward14€145,840
Amounts payable17/49€45,384
Amounts payable within one year42/48€45,384
Trade debts44€434
Suppliers440/4€434
Taxes, remuneration and social security45€41,960
Taxes450/3€41,960
Other amounts payable47/48€2,990
Line2025
Profit (loss) for the period9904€145,840
Operating cash flow (approximation)€145,840

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
11-09
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 42 days late
NBB filing

Directors · office · real estate

Directors
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
Location & real-estate footprint
Registered office, Bilzen-Hoeselt · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
2,294 m²
Building footprint
317 m²
Volume, LiDAR
1,390 m³
Parcel 73006G1197/00A000, Flanders · tallest building 10.1 m, ±2 floors. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
YnoraMed
Pijpenhof 29A, 3740 Bilzen-HoeseltGeneral medical practice
since 20242.367.567.882
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
73006G1197/00A000 Flanders 2,294 m² 1 · 316 m² 10.1 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded16-12-2024
Fiscal year end31-12
E-invoicing
Reachable via Peppol
Peppol ID 0208:1017416073
Also 9925:BE1017416073
Registered 08-09-2026

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.